Structural and functional cardiac changes are target organ damage that increases risk of atrial fibrillation

Journal of the American College of Cardiology

Volumn 63, Issue 19, 2014, Pages 2014-2015

  Wachtell, Kristian ^a   Greve, Anders M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

atrial fibrillation; cardiac magnetic resonance imaging; electrocardiogram; left ventricular hypertrophy

Indexed keywords

ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE COURSE; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NOTE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK REDUCTION; SCREENING; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; ECHOCARDIOGRAPHY; EDITORIAL; HEART FUNCTION; HEART HEMODYNAMICS; PATHOLOGICAL ANATOMY;

ATRIAL FIBRILLATION; CARDIAC MAGNETIC RESONANCE IMAGING; ELECTROCARDIOGRAM; LEFT VENTRICULAR HYPERTROPHY;

ATHEROSCLEROSIS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE;

PLACEBO; RAMIPRIL;

EID: 84900563908     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.548     Document Type: Editorial

References (11)

1. R.B. Devereux, and M.H. Alderman Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events Circulation 88 1993 1444 1455
2. R.H. Falk Atrial fibrillation N Engl J Med 344 2001 1067 1078
3. K. Wachtell, E. Gerdts, and G.P. Aurigemma et al. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the LIFE study Blood Press 19 2010 169 175
4. P.M. Okin, K. Wachtell, and R.B. Devereux et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension JAMA 296 2006 1242 1248
5. K. Wachtell Atrial fibrillation, maybe it is not so lone? J Am Coll Cardiol 53 2009 30 31
6. F. Belluzzi, L. Sernesi, P. Preti, F. Salinaro, M.L. Fonte, and S. Perlini Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients J Am Coll Cardiol 53 2009 24 29
7. J. Chrispin, A. Jain, and E.Z. Soliman et al. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 63 2014 2007 2013
8. G. de Simone, and R.B. Devereux What is bright is not always gold Hypertension 41 2003 e9 e10
9. W.G. Hundley, D.A. Bluemke, and J.P. Finn et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2614 2662
10. L. Bacharova, V. Szathmary, M. Kovalcik, and A. Mateasik Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study J Electrocardiol 43 2010 200 208
11. K.F. Kerr, Z. Wang, H. Janes, R.L. McClelland, B.M. Psaty, and M.S. Pepe Net reclassification indices for evaluating risk prediction instruments: a critical review Epidemiology 25 2014 114 121